Zebra Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Zebra Capital Management’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-559	Closed	-$12K	–	191
2021 Q4	$12K	Hold	559	–	–	0.02%	155
2021 Q3	$18K	Sell	559 -3,706	-87%	-$136K	0.02%	182
2021 Q2	$178K	Sell	4,265 -400	-9%	-$20.5K	0.21%	142
2021 Q1	$306K	Buy	4,665 +4,106	+735%	+$286K	0.34%	108
2020 Q4	$37K	Hold	559	–	–	0.05%	160
2020 Q3	$30K	Hold	559	–	–	0.05%	162
2020 Q2	$53K	Hold	559	–	–	0.08%	204
2020 Q1	$29K	Sell	559 -178	-24%	-$18.6K	0.05%	216
2019 Q4	$61K	Sell	737 -535	-42%	-$37.5K	0.05%	277
2019 Q3	$108K	Buy	1,272 +900	+242%	+$96.1K	0.12%	211
2019 Q2	$47K	Sell	372 -149	-29%	-$21.5K	0.02%	451
2019 Q1	$94K	Buy	521 +79	+18%	+$11.4K	0.05%	420
2018 Q4	$49K	Sell	442 -77	-15%	-$10K	0.03%	374
2018 Q3	$70K	Buy	519 +49	+10%	+$6.75K	0.03%	413
2018 Q2	$65K	Hold	470	–	–	0.03%	326
2018 Q1	$65K	Buy	470 +97	+26%	+$13.2K	0.02%	330
2017 Q4	$46K	Buy	+373	New	+$51.2K	0.02%	319

Other funds holding SRGA

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Zebra Capital Management's SRGA Position: Q1 2022 in Review

Zebra Capital Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q1 2022, closing a stake of 559 shares — an estimated $12K sold.

Zebra Capital Management first reported a position in SRGA in Q4 2017 and held it in 17 quarters. The position peaked at $306K in Q1 2021. 77 funds tracked by Wall St. Rank hold SRGA as of Q1 2022.

Zebra Capital Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Zebra Capital Management sold 559 Surgalign Holdings, Inc. Common Stock shares in Q1 2022, an estimated $12K.
Zebra Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q4 2017 and held it in 17 quarters.
Zebra Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $306K in Q1 2021.
77 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q1 2022.

Based on Zebra Capital Management's 13F filing for Q1 2022, filed 16 May 2022.